There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To investigate baseline predictors of month 24 best-corrected visual acuity (BCVA)
and central foveal thickness (CFT) in patients with diabetic macular edema (DME) treated
monthly with ranibizumab or sham.